1. Home
  2. UAA vs HAE Comparison

UAA vs HAE Comparison

Compare UAA & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UAA

Under Armour Inc.

HOLD

Current Price

$5.84

Market Cap

2.6B

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$74.43

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UAA
HAE
Founded
1996
1971
Country
United States
United States
Employees
14100
N/A
Industry
Apparel
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
UAA
HAE
Price
$5.84
$74.43
Analyst Decision
Hold
Buy
Analyst Count
16
9
Target Price
$6.48
$84.13
AVG Volume (30 Days)
7.0M
984.8K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.05
Revenue
N/A
$910,373,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.57
$5.23
P/E Ratio
N/A
$37.52
Revenue Growth
N/A
N/A
52 Week Low
$4.13
$47.32
52 Week High
$8.15
$87.32

Technical Indicators

Market Signals
Indicator
UAA
HAE
Relative Strength Index (RSI) 54.09 62.97
Support Level $5.39 $48.98
Resistance Level $6.10 $86.72
Average True Range (ATR) 0.24 3.25
MACD 0.07 0.53
Stochastic Oscillator 66.07 55.12

Price Performance

Historical Comparison
UAA
HAE

About UAA Under Armour Inc.

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 440 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: